Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study
- PMID: 10901330
- PMCID: PMC2215380
- DOI: 10.1093/aje/152.1.59
Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study
Abstract
To investigate the effect of aluminum and silica in drinking water on the risk of dementia and Alzheimer's disease, the authors analyzed data from a large prospective cohort (Paquid), including 3,777 subjects aged 65 years and over living at home in 75 civil parishes in Gironde and Dordogne in southwestern France in 1988-1989. The subjects were followed for up for 8 years with an active search for incident cases of dementia or Alzheimer's disease. Mean exposure to aluminum and silica in drinking water was estimated in each area. The sample studied included 2,698 nondemented subjects at baseline, for whom components of drinking water and covariates were available. A total of 253 incident cases of dementia (with 17 exposed to high levels of aluminum), including 182 Alzheimer's disease (with 13 exposed to high aluminum levels), were identified. The relative risk of dementia adjusted for age, gender, educational level, place of residence, and wine consumption was 1.99 (95 percent CI: 1.20, 3.28) for subjects exposed to an aluminum concentration greater than 0.1 mg/liter. This result was confirmed for Alzheimer's disease (adjusted relative risk = 2.14, 95 percent CI: 1.21, 3.80). However, no dose-response relation was found. Inversely, the adjusted relative risk of dementia for subjects exposed to silica (> or = 11.25 mg/liter) was 0.74 (95 percent CI: 0.58, 0.96). These findings support the hypothesis that a high concentration of aluminum in drinking water may be a risk factor for Alzheimer's disease.
Comment in
-
Re: aluminum in drinking water and cognitive decline in elderly subjects: the Paquid cohort.Am J Epidemiol. 2001 Aug 1;154(3):288-90. doi: 10.1093/aje/154.3.288-a. Am J Epidemiol. 2001. PMID: 11479195 Free PMC article. No abstract available.
References
-
- Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–925. - PubMed
-
- McLachlan DRC. Aluminium and the risk for Alzheimer’s disease. Environmetrics. 1995;6:233–275.
-
- Huang Y, Herman MM, Liu J, Katsetos CD, Wills MR, Savory J. Neurofibrillary lesions in experimental aluminium-induced encephalopathy and Alzheimer’s disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquity-protein conjugates. Brain Res. 1997;771:213–220. - PubMed
-
- Cucarella C, Montoliu C, Hermenegildo C, et al. Chronic exposure to aluminium impairs neuronal glutamate-nitric oxide-cyclic pathway. J Neurochem. 1998;70:1609–1614. - PubMed
-
- Roberts NB, Clough A, Bellia JP, Kim JY. Increased absorption of aluminium from a normal dietary intake in dementia. J Inorg Biochem. 1998;69:171–176. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
